Oncolytics biotech Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Oncolytics biotech Contact Number

Contact :: Oncolytics Biotech, Inc. (ONCY)

2 hours ago Oncolyticsbiotech.com Get All

San Diego, California 4660 La Jolla Village Dr. Ste. 850 San Diego, CA 92122

Website: https://www.oncolyticsbiotech.com/contact/

Category: Contact Support, Tech SupportShow more

Oncolytics Biotech, Inc. (ONCY)

4 hours ago Oncolyticsbiotech.com Get All

Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results. Aug 6, 2021. Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 41st Annual Growth Conference. Jul 22, 2021. Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational

Website: https://www.oncolyticsbiotech.com/

Category: Tech SupportShow more

Oncolytics Biotech Crunchbase Company Profile & Funding

8 hours ago Crunchbase.com Get All

403.670.7377

Company Type For Profit. Contact Email [email protected]oncolyticsbiotech.com. Phone Number 403.670.7377. Oncolytics Biotech focuses the research and development efforts on the development of REOLYSIN, the cancer therapeutic. The product for human use, REOLYSIN is developed from the reovirus. The virus has been demonstrated to replicate in the tumour cells

Website: https://www.crunchbase.com/organization/oncolytics-biotech

Category: Tech SupportShow more

IR Contacts :: Oncolytics Biotech, Inc. (ONCY)

Just Now Ir.oncolyticsbiotech.com Get All

Ernst & Young LLP 215 2nd St. SW, Suite 2200 Calgary, AB T2P 1M4

Website: https://ir.oncolyticsbiotech.com/investor-contacts

Category: Contact Support, Tech SupportShow more

Oncolytics Biotech Inc. Profile SEDAR

3 hours ago Sedar.com Get All

403 670-7377

Oncolytics Biotech Inc. Mailing Address: 804, 322 11 Avenue SW Calgary, Alberta T2R 0C5: Head Office Address: 804, 322 11 Avenue SW Calgary, Alberta T2R 0C5: Contact Name: Kirk Look: Principal Regulator: Alberta: Business e-mail address: [email protected]: Short Form Prospectus Issuer: Yes: Telephone Number: 403 670-7377: Reporting

Contact Name: Kirk Look
Principal Regulator: Alberta

Website: https://sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00013081

Category: Tech SupportShow more

FAQs :: Oncolytics Biotech, Inc. (ONCY)

7 hours ago Ir.oncolyticsbiotech.com Get All

The CUSIP number of Oncolytics' common stock is 682310. Who is Oncolytics' transfer agent and how do I contact them? Oncolytics' transfer agent is AST Trust Company. The contact information for AST is on our IR Contacts page. How do I change my address on my stockholder account? To change your address on your stockholder account, contact

Website: https://ir.oncolyticsbiotech.com/faqs

Category: Tech SupportShow more

Oncolytics Biotech Company Profile Office Locations

5 hours ago Craft.co Get All

Oncolytics Biotech has 3.09k Twitter Followers. The number of followers has increased 0.1% month over month and decreased 0.5% quarter over quarter

Website: https://craft.co/oncolytics-biotech

Category: Tech SupportShow more

Grey Wilkinson Scientist, Tr.. Oncolytics Biotech

3 hours ago Zoominfo.com Get All

View Grey Wilkinson's business profile as Scientist, Translational Medicine at Oncolytics Biotech. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Grey-Wilkinson/-1520623613

Category: Tech SupportShow more

Board of Directors :: Oncolytics Biotech, Inc. (ONCY)

8 hours ago Oncolyticsbiotech.com Get All

Ms. Holtham held a number of financial positions over a 19-year career with the Canadian subsidiary of Nabisco Inc., rising to become Senior Vice President and Chief Financial Officer. In 2002, she joined Toronto, Ontario-based Hospital for Sick Children as Vice President, Finance and Chief Financial Officer, a position she held for eight years.

Website: https://www.oncolyticsbiotech.com/about/board-of-directors

Category: Tech SupportShow more

ONCOLYTICS BIOTECH INC (ONC.TO) Company Profile & Facts

6 hours ago Finance.yahoo.com Get All

See the company profile for ONCOLYTICS BIOTECH INC (ONC.TO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Website: https://finance.yahoo.com/quote/ONC.TO/profile

Category: Tech SupportShow more

Oncolytics Biotech Inc. (ONCY) Company Profile & Facts

4 hours ago Finance.yahoo.com Get All

See the company profile for Oncolytics Biotech Inc. (ONCY) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Website: https://finance.yahoo.com/quote/ONCY/profile

Category: Tech SupportShow more

Oncolytics Biotech Inc. Home Facebook

7 hours ago Facebook.com Get All

Oncolytics Biotech Inc. September 19, 2017 ·. Dr. Andres Gutierrez, Oncolytics’ Chief Medical Officer, will present at the Phacilitate Immuno-Oncology Frontiers Conference at 4:00 pm CEST on September 21, 2017 at the Maritim Proarte Hotel in Berlin, Germany. He will highlight the role of REOLYSIN in the activation of the immune system and

Website: https://www.facebook.com/Oncolytics.Biotech.Inc

Category: Home Phone, Tech SupportShow more

Oncolytics Biotech Inc. 6K May. 10, 2021 9:04 AM

9 hours ago Seekingalpha.com Get All

Growth Stocks. Potential Multibaggers; Crypto

Website: https://seekingalpha.com/filing/5520068

Category: Tech SupportShow more

Corporate Governance :: Oncolytics Biotech, Inc. (ONCY)

3 hours ago Ir.oncolyticsbiotech.com Get All

Governance Committee. Science and Technology Committee. Wayne Pisano. Chair. Mr. Pisano has more than 30 years of experience as a pharmaceutical industry executive and was recognized in 2010 as Pharma Executive of the Year by the World Vaccine Congress. He served as the president and CEO of VaxInnate a privately held biotech company.

Website: https://ir.oncolyticsbiotech.com/corporate-governance

Category: Tech SupportShow more

Oncolytics Biotech® Reports 2020 Second Quarter Financial

6 hours ago Oncolyticsbiotech.com Get All

403-670-7658

Company Contact . Kirk Look. Chief Financial Officer +1-403-670-7658 . [email protected]oncolytics.ca . Investor Relations for Oncolytics. Timothy McCarthy. LifeSci Advisors +1-212-915-2564. [email protected]

Website: https://www.oncolyticsbiotech.com/press-releases/detail/513/oncolytics-biotech-reports-2020-second-quarter-financial

Category: Tech SupportShow more

Oncolytics Biotech Inc. LinkedIn

6 hours ago Linkedin.com Get All

Oncolytics Biotech Inc. 2,565 followers on LinkedIn. Innately Adaptive® Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immuno-oncolytic

Website: https://www.linkedin.com/company/oncolytics-biotech-inc.

Category: Tech SupportShow more

Oncolytics Biotech® Announces Annual General Meeting

6 hours ago Oncolyticsbiotech.com Get All

Management will also provide its annual corporate update after the conclusion of the meeting. SAN DIEGO, Calif. and CALGARY, AB, April 30, 2021 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), (the "Company") today announced that its upcoming 2021 Annual General Meeting (the "Meeting") will be held virtually at 12:00 p.m. Eastern Daylight Time (ET) on Friday, May 7, 2021.

Website: https://www.oncolyticsbiotech.com/press-releases/press-releases/detail/537/oncolytics-biotech-announces-annual-general-meeting

Category: Tech SupportShow more

Email Alerts :: Oncolytics Biotech, Inc. (ONCY)

5 hours ago Ir.oncolyticsbiotech.com Get All

Email Alerts. Please fill out the form below to receive company press releases via email when they occur. First Name: Last Name: Company Name: Email: Contact Type: Individual Investor Analyst Broker/Investment Advisor Portfolio Manager Banker/Financing Source Press/Media Consultant Employee Customer/Client Student Other.

Website: https://ir.oncolyticsbiotech.com/email-alerts

Category: Tech SupportShow more

ONCY Oncolytics Biotech Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Get All

SAN DIEGO and CALGARY, AB, July 22, 2021 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, August 6, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the second quarter 2021.

Website: https://www.biopharmcatalyst.com/company/ONCY

Category: Tech SupportShow more

Oncolytics Biotech (ONCY) Company Profile & Overview

6 hours ago Stockanalysis.com Get All

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with

Website: https://stockanalysis.com/stocks/oncy/company/

Category: Tech SupportShow more

Oncolytics Biotech® Reports 2021 Second Quarter

5 hours ago Ir.oncolyticsbiotech.com Get All

858-886-7813

Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results. Download as PDF. clinical proof-of-concept data in metastatic pancreatic cancer demonstrate pelareorep's broad applicability to a number of different tumor types Company Contact . Jon Patton. Director of IR & Communication +1-858-886-7813.

Website: https://ir.oncolyticsbiotech.com/press-releases/detail/545/oncolytics-biotech-reports-2021-second-quarter

Category: Tech SupportShow more

Oncolytics Biotech® to Present AWARE1 Data and Provide

2 hours ago Nasdaq.com Get All

SAN DIEGO, Calif. and CALGARY, Alberta, Nov. 17, 2020/ PRNewswire/-- Oncolytics Biotech ® Inc. today announced the publication of three abstracts for …

Website: https://www.nasdaq.com/press-release/oncolytics-biotechr-to-present-aware-1-data-and-provide-updates-on-phase-2-bracelet-1

Category: Tech SupportShow more

Oncolytics Biotech Inc. ONCY:NASDAQ; ONC:TSX

5 hours ago Streetwisereports.com Get All

Oncolytics' clinical program includes a number of human trials at a variety of stages including a phase 3 trial in head and neck cancers. The company has advanced its product manufacturing and intellectual property initiatives parallel to its clinical development program …

Website: https://www.streetwisereports.com/pub/co/4849

Category: Tech SupportShow more

Oncolytics Biotech Inc. 6K Apr. 30, 2021 10:31 AM

9 hours ago Seekingalpha.com Get All

SAN DIEGO, CA and CALGARY, AB, April 30, 2021 --Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), (the “Company”) today announced that its upcoming 2021 Annual General Meeting (the

Website: https://seekingalpha.com/filing/5501295

Category: Tech SupportShow more

Oncolytics Biotech Inc. (ONCY) Stock Price, News, Quote

6 hours ago Finance.yahoo.com Get All

Find the latest Oncolytics Biotech Inc. (ONCY) stock quote, history, news and other vital information to help you with your stock trading and investing. Contact Us; U.S. markets closed. S&P

Website: https://finance.yahoo.com/quote/ONCY

Category: Tech SupportShow more

Oncolytics Biotech® and SOLTI Present Clinical Breast

5 hours ago Nasdaq.com Get All

SAN DIEGO, CA and CALGARY, AB, Nov. 9, 2020/ PRNewswire/-- Oncolytics Biotech ® Inc. and SOLTI-Innovative Breast Cancer Research …

Website: https://www.nasdaq.com/press-release/oncolytics-biotechr-and-solti-present-clinical-breast-cancer-data-highlighting

Category: Tech SupportShow more

Oncolytics Biotech Number of Employees 20062021 ONCY

5 hours ago Macrotrends.net Get All

Oncolytics Biotech number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide

Website: https://www.macrotrends.net/stocks/charts/ONCY/oncolytics-biotech/number-of-employees

Category: Tech SupportShow more

Reolysin Trademark Oncolytics Biotech Inc. Bizapedia

9 hours ago Bizapedia.com Get All

Reolysin is a Trademark by Oncolytics Biotech Inc., the address on file for this trademark is 210, 1167 Kensington Crescent Nw, Calgary Alberta T2N 1X7

Website: https://www.bizapedia.com/trademarks/reolysin-75864483.html

Category: Tech SupportShow more

Oncolytics Biotech® Announces Voting Results from the

8 hours ago Nasdaq.com Get All

858-886-7813

Company Contact Jon Patton Director of IR & Communication +1-858-886-7813 [email protected]oncolytics.ca Investor Relations for Oncolytics Timothy McCarthy LifeSci Advisors +1 …

Website: https://www.nasdaq.com/press-release/oncolytics-biotechr-announces-voting-results-from-the-annual-general-meeting-of-0

Category: Tech SupportShow more

Oncolytics Biotech® Announces Annual General Meeting Nasdaq

Just Now Nasdaq.com Get All

SAN DIEGO, Calif. and CALGARY, AB, April 30, 2021/ PRNewswire/-- Oncolytics Biotech ® Inc., today announced that its upcoming 2021 …

Website: https://www.nasdaq.com/press-release/oncolytics-biotechr-announces-annual-general-meeting-2021-04-30

Category: Tech SupportShow more

Oncolytics Biotech® Reports Fourth Quarter and Full Year

7 hours ago Finance.yahoo.com Get All

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and operational highlights for the quarter and year ended December 31, 2020. an unlimited number

Website: https://finance.yahoo.com/news/oncolytics-biotech-reports-fourth-quarter-123000184.html

Category: Tech SupportShow more

Oncolytics Biotech® Reports 2021 Second Quarter

Just Now Wfmz.com Get All

SAN DIEGO and CALGARY, AB, Aug. 6, 2021 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and development highlights for the quarter ended

Website: https://www.wfmz.com/news/pr_newswire/pr_newswire_business/oncolytics-biotech-reports-2021-second-quarter-development-highlights-and-financial-results/article_20f8b11b-2981-5dd8-9830-fc561ece36a5.html

Category: Tech SupportShow more

Oncolytics Biotech® Reports 2021 Second Quarter

6 hours ago Benzinga.com Get All

SAN DIEGO and CALGARY, AB, Aug. 6, 2021 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ:ONCY) (TSX:ONC) today announced its financial results and development highlights for the quarter ended June 30

Website: https://www.benzinga.com/pressreleases/21/08/n22370521/oncolytics-biotech-reports-2021-second-quarter-development-highlights-and-financial-results

Category: Tech SupportShow more

Oncolytics Biotech® Reports 2020 Third Quarter Development

Just Now Nasdaq.com Get All

SAN DIEGO, and CALGARY, AB, Nov. 11, 2020/ PRNewswire/-- Oncolytics Biotech ® Inc. today announced its financial results and operational highlights for …

Website: https://www.nasdaq.com/press-release/oncolytics-biotechr-reports-2020-third-quarter-development-highlights-and-financial

Category: Tech SupportShow more

Oncolytics Biotech® Reports 2021 Second Quarter

4 hours ago Finance.yahoo.com Get All

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and development highlights for the quarter ended …

Website: https://finance.yahoo.com/news/oncolytics-biotech-reports-2021-second-110000343.html

Category: Tech SupportShow more

Oncolytics Biotech Inc. 6K Dec. 9, 2020 10:22 AM

9 hours ago Seekingalpha.com Get All

Growth Stocks. Potential Multibaggers; Crypto

Website: https://seekingalpha.com/filing/5266109

Category: Tech SupportShow more

Oncolytics Biotech Stock Analysis 2021 ONCY Macroaxis

4 hours ago Macroaxis.com Get All

The current slide in stock price may encourage investors to take a closer look at the company as it is trading at a share price of 2.09 on 235,607 in trading volume. The company directors and management have failed to build on market volatilities in July.However, diversifying your overall positions with Oncolytics Biotech may protect your principal portfolio during upcoming market swings.

Website: https://www.macroaxis.com/stock-analysis/ONCY/Oncolytics-Biotech

Category: Tech SupportShow more

Oncolytics Biotech® Announces Annual General Meeting

4 hours ago Biospace.com Get All

Management will also provide its annual corporate update after the conclusion of the meeting. SAN DIEGO, Calif. and CALGARY, AB, April 30, 2021 /PRNewswire/ -- Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), (the "Company") today announced that its upcoming 2021 Annual General Meeting (the "Meeting") will be held virtually at 12:00 p.m. Eastern Daylight Time (ET) on …

Website: https://www.biospace.com/article/releases/oncolytics-biotech-announces-annual-general-meeting/

Category: Tech SupportShow more

Oncolytics Biotech's (ONCY) CoDevelopment Agreement with

8 hours ago Seekingalpha.com Get All

Oncolytics Biotech, Inc. (NASDAQ:ONCY) Oncolytics Co-Development Agreement Call June 5, 2019 8:30 AM ET Company Participants Michael Moore …

Website: https://seekingalpha.com/article/4268528-oncolytics-biotechs-oncy-co-development-agreement-pfizer-and-merck-kgaa-call-transcript

Category: Tech SupportShow more

Oncolytics Biotech® to Host Conference Call to Discuss

8 hours ago Ca.finance.yahoo.com Get All

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, August 6, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the second quarter 2021.

Website: https://ca.finance.yahoo.com/news/oncolytics-biotech-host-conference-call-110000785.html

Category: Tech SupportShow more

Oncolytics Biotech® Updates Clinical Development and

4 hours ago Bloomberg.com Get All

212-915-2564

Company Contact Investor Relations for Oncolytics Michael Moore Timothy McCarthy Investor Relations & Corporate LifeSci Advisors Communications 212-915-2564 858-886-7813 [email protected]

Website: https://www.bloomberg.com/press-releases/2020-04-17/oncolytics-biotech-updates-clinical-development-and-operations-activities-during-the-covid-19-pandemic

Category: Tech SupportShow more

Oncolytics Biotech® Announces Annual General Meeting

Just Now Markets.businessinsider.com Get All

Management will also provide its annual corporate update after the conclusion of the meeting. SAN DIEGO, Calif. and CALGARY, AB, April 30, 2021 /PRNewswire/ -- Oncolytics Biotech

Website: https://markets.businessinsider.com/news/stocks/oncolytics-biotech-announces-annual-general-meeting-1030369837

Category: Tech SupportShow more

Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2021

8 hours ago Seekingalpha.com Get All

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2021 Results Earnings Conference Call August 06, 2021, 08:00 AM ET Company Participants Jon Patton - …

Website: https://seekingalpha.com/article/4446064-oncolytics-biotech-inc-oncy-ceo-matt-coffey-on-q2-2021-results-earnings-call-transcript

Category: Tech SupportShow more

Oncolytics Biotech® Announces Annual General Meeting

6 hours ago Eresearch.fidelity.com Get All

Management will also provide its annual corporate update after the conclusion of the meeting. SAN DIEGO, Calif. and CALGARY, AB, April 30, 2021 /PRNewswire/ -- Oncolytics Biotech ® Inc. , (the "Company") today announced that its upcoming 2021 Annual General Meeting (the "Meeting") will be held virtually at 12:00 p.m. Eastern Daylight Time (ET) on Friday, May 7, 2021.

Website: https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=ONCY&storyid=202104300700PR_NEWS_USPR_____LN61407&sb=1

Category: Tech SupportShow more

Oncolytics Biotech : reg; Reports 2021 Second Quarter

5 hours ago Marketscreener.com Get All

Oncolytics Biotech : reg; Reports 2021 Second Quarter Development Highlights and Financial Results. 08/06/2021 07:01am EDT clinical proof-of-concept data in metastatic pancreatic cancer demonstrate pelareorep's broad applicability to a number of different tumor types Company Contact . Jon Patton. Director of IR & Communication +1-858

Website: https://www.marketscreener.com/quote/stock/ONCOLYTICS-BIOTECH-INC-43524077/news/Oncolytics-Biotech-reg-Reports-2021-Second-Quarter-Development-Highlights-and-Financial-Results-36090607/

Category: Tech SupportShow more

How to buy Oncolytics Biotech stock (NASDAQ: ONCY) stock

1 hours ago Finder.com Get All

Over the last 12 months, Oncolytics Biotech's shares have ranged in value from as little as $1.55 up to $4.83. A popular way to gauge a stock's volatility is its "beta". Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oncolytics Biotech's is 1.8118.

Website: https://www.finder.com/buy-oncolytics-biotech-stock

Category: Tech SupportShow more

Is Oncolytics Biotech, Inc. (ONCY) a Good Buy in the

8 hours ago Investorsobserver.com Get All

Oncolytics Biotech, Inc. (ONCY) stock is trading at $3.57 as of 10:52 AM on Monday, Apr 12, a loss of -$0.44, or -10.97% from the previous closing price of $4.01. The stock has traded between $3.54 and $4.07 so far today. Volume today is 1,518,873 compared to …

Website: https://www.investorsobserver.com/news/stock-update/is-oncolytics-biotech-inc-oncy-a-good-buy-in-the-healthcare-sector

Category: Tech SupportShow more

ONCY Stock News ONCOLYTICS BIOTECH Stock Price Today

3 hours ago Markets.businessinsider.com Get All

Number of Shares. 2.03 Day Low. 2.17 Day High. 2.15. 1.55 Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological

Website: https://markets.businessinsider.com/stocks/oncy-stock

Category: Tech SupportShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is the stock price of oncolytics biotech?

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and development highlights for the quarter ended March 31, 2021. All dollar amounts are expressed in Canadian currency unless otherwise noted.

When is oncolytics biotechs annual general meeting?

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting of Shareholders held on Friday, May 7, 2021. A total of 41.41% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting.

When was oncolytics biotech incfounded in calgary?

History. Oncolytics Biotech Inc. was founded in Calgary in 1998 in response to discoveries made on the oncolytic potential of reovirus made at the University of Calgary during the 1990s. In June 2000, it began trading on the Toronto Stock Exchange (TSX). Since its inception, Oncolytics Biotech Inc.

Who was the chief scientific officer of oncolytics?

Since co-founding Oncolytics he has also held the positions of Chief Scientific Officer from December 2004 to December 2008, Vice-President of Product Development from July 1999 to December 2004 and Chief Financial Officer from September 1999 to May 2000.

Brand New Updated

Popular Brands

Olam
Oracle
Orix
Okta
Oneok
Omv
Orpea
Orsted
Opera
Omron